Free Trial
TSE:TRL

Trilogy International Partners (TRL) Stock Price, News & Analysis

Trilogy International Partners logo

About Trilogy International Partners Stock (TSE:TRL)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
239,293 shs
Average Volume
68,686 shs
Market Capitalization
C$21.27 million
P/E Ratio
0.04
Dividend Yield
704.17%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive TRL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Trilogy International Partners and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TRL Stock News Headlines

Take a look at this picture ...
A strange investment secret — discovered just a few short weeks before this image was taken — correctly predicted it all. Even crazier, this secret accurately called every major financial event in recent history … Now it's signaling something very scary is about to hit the market again …tc pixel
Trilogy International Partners Inc TRL.H
See More Headlines

TRL Stock Analysis - Frequently Asked Questions

Shares of TRL stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Trilogy International Partners investors own include Acerus Pharmaceuticals (ASP), Millicom International Cellular (TIGO), Emera (EMA), Merck & Co., Inc. (MRK), NFI Group (NFI), (ONCYF) (ONCYF) and ARK Autonomous Technology & Robotics ETF (ARKQ).

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
Medical
Industry
Drug Manufacturers - Major
Sub-Industry
Healthcare
Current Symbol
TSE:TRL
Previous Symbol
TSE:AQX.A
CIK
N/A
Web
N/A
Fax
N/A
Employees
70,000
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
0.04
Forward P/E Ratio
N/A
P/E Growth
0.86
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
5.92
Quick Ratio
3.87

Sales & Book Value

Annual Sales
C$407.64 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
0.77
Book Value
C$0.38 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
88,628,000
Free Float
N/A
Market Cap
C$21.27 million
Optionable
Not Optionable
Beta
N/A
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (TSE:TRL) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners